All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.

  TRANSLATE

The SOT Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the SOT Hub cannot guarantee the accuracy of translated content. The SOT Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The Solid Organ Transplantation Hub is an independent medical education platform, sponsored by Therakos. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

Impact of FWIT on outcomes following DCD heart transplantation

By Megan Moore

Share:

Oct 30, 2026

Learning objective: After reading this article, learners will be able to cite a new clinical development in heart transplantation.


Results from a single-center, retrospective, observational study, evaluating the impact of functional warm ischemic time (FWIT) on outcomes in adult heart transplant recipients receiving donation after circulatory death (DCD) hearts recovered using direct procurement and perfusion (DPP), were published in the Journal of Heart and Lung Transplantation by Khan et al. The primary outcomes were severe primary graft dysfunction (PGD) and all-cause mortality.  

Key data: Among 125 recipients, FWIT was ≤30 minutes in 69.6% and >30 minutes in 30.4%. During a median follow-up of 5.4 years, 24 deaths occurred. Severe PGD occurred in 23.2% of recipients. After adjustment for donor age and total ischemic time, FWIT was not independently associated with all-cause mortality (hazard ratio [HR], 1.11; 95% confidence interval [CI], 0.83–1.46; p = 0.49). There was no significant difference between the ≤30- and >30-minute groups in 1-year survival (88.8% vs 84.4%; p = 0.75), incidence of severe PGD (23.0% vs 23.7%; p > 0.99), or post-transplant mechanical circulatory support (MCS) requirement (23.0% vs 31.6%; p = 0.31). 

Key learning: In this study, FWIT >30 minutes was not associated with significantly worse outcomes than FWIT ≤30 minutes in adults undergoing DCD heart transplantation using DPP. These findings suggest that donor hearts with FWIT >30 minutes should undergo comprehensive evaluation rather than be excluded based on FWIT alone. Larger, multicenter studies are needed to better define the safety and efficacy of prolonged FWIT in DCD heart transplantation. 

References

Please indicate your level of agreement with the following statements:

The content was clear and easy to understand

The content addressed the learning objectives

The content was relevant to my practice

I will change my clinical practice as a result of this content

This content is accurate as of the date of publication and is not updated retrospectively. Please refer to the latest available evidence, guidelines, and relevant regulatory information when making clinical decisions.

Your opinion matters

Which topic, relating to ECP, do you think would be the most valuable educational content for the SOT Hub?